Literature DB >> 19483300

Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation.

Hai Shi1, Haifeng Jin, Dake Chu, Weizhong Wang, Jian Zhang, Changsheng Chen, Chunsheng Xu, Daiming Fan, Libo Yao.   

Abstract

NDRG2, a new member of the N-Myc downstream-regulated gene (NDRG) family, is a focus for study at present. Up to now, its expression and function in carcinoma remain to be elucidated. In this study, using a colorectal cancer tissue array and a series of 213 colorectal cancer samples, the relationship between Ndrg2 and c-MYC expression and tumor differentiation level was investigated. Immunohistochemistry showed that Ndrg2 expression was reduced and that c-Myc was increased in colorectal carcinomas. In addition, Ndrg2 protein levels increased from poorly differentiated to well-differentiated carcinomas (p=0.005). Real-time polymerase chain reaction and Western blots demonstrated quantitatively that NDRG2 mRNA and protein levels were lower in colorectal carcinomas compared to the adjacent tissue and normal tissue from the same individual (p=3x10(-8)). Also, the NDRG2 expression level in adjacent carcinoma tissue was lower than that of normal tissue. However, the expression pattern of c-MYC was the inverse (p=5x10(-8)). Finally, we induced the differentiation of the colorectal carcinoma cell lines HT29, SW480 and SW620 and found that NDRG2 expression increased and that c-MYC expression declined with increasing differentiation. These novel data show a disparity in both the mRNA and protein expression levels of Ndrg2 and c-Myc between colorectal cancers and normal tissues. Taken together, NDRG2 may play a role during the differentiation of colorectal cancer cells, and the function of NDRG2 in the development of colorectal cancer should be further investigated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19483300     DOI: 10.1248/bpb.32.968

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  17 in total

1.  Ndrg2 expression in neurogenic germinal zones of embryonic and postnatal mouse brain.

Authors:  Lijuan Liu; Ming Shi; Li Wang; Shuangxing Hou; Zhongliang Wu; Gang Zhao; Yanchun Deng
Journal:  J Mol Histol       Date:  2011-12-06       Impact factor: 2.611

2.  DNA methylation of NDRG2 in gastric cancer and its clinical significance.

Authors:  Xiaojing Chang; Zhenhua Li; Jinguo Ma; Peng Deng; Shuanglong Zhang; Yu Zhi; Jing Chen; Dongqiu Dai
Journal:  Dig Dis Sci       Date:  2012-09-26       Impact factor: 3.199

3.  NDRG4 is downregulated in glioblastoma and inhibits cell proliferation.

Authors:  Wenchao Ding; Jing Zhang; Jae-Geun Yoon; Dongyan Shi; Gregory Foltz; Biaoyang Lin
Journal:  OMICS       Date:  2012-04-10

Review 4.  Significant position of C-myc in colorectal cancer: a promising therapeutic target.

Authors:  Li Tan; Dong Peng; Yong Cheng
Journal:  Clin Transl Oncol       Date:  2022-08-16       Impact factor: 3.340

5.  Expression and prognostic value of the aldehyde dehydrogenase 1 (ALDH1) and N-myc downstream regulated gene 2 (NDRG2) as potential markers in human astrocytomas.

Authors:  Peyman Karimi Goudarzi; Farzad Mehrabi; Reza Jalili Khoshnood; Ali Baradaran Bagheri; Koorosh Ahmadi; Emad Yahaghi; Hesam Abdolhoseinpour
Journal:  Tumour Biol       Date:  2015-11-30

6.  Expression of MSP58 in human colorectal cancer and its correlation with prognosis.

Authors:  Hai Shi; Shu-Jun Li; Bo Zhang; He-Liang Liu; Chang-Sheng Chen
Journal:  Med Oncol       Date:  2012-07-08       Impact factor: 3.064

7.  Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Authors:  Hai Shi; Yi Zhou; Heliang Liu; Changsheng Chen; Shujun Li; Nanlin Li; Xiaohua Li; Xi Zhang; Hongwei Zhang; Weizhong Wang; Qingchuan Zhao
Journal:  BMC Cancer       Date:  2010-09-03       Impact factor: 4.430

8.  NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients.

Authors:  Dake Chu; Zixi Zhang; Yi Zhou; Yunming Li; Shaojun Zhu; Jian Zhang; Qingchuan Zhao; Gang Ji; Weizhong Wang; Jianyong Zheng
Journal:  Oncotarget       Date:  2015-04-10

9.  Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression.

Authors:  Junye Liu; Le Yang; Jian Zhang; Jing Zhang; Yongbin Chen; Kangchu Li; Yurong Li; Yan Li; Libo Yao; Guozhen Guo
Journal:  BMC Cancer       Date:  2012-08-27       Impact factor: 4.430

10.  A statin-regulated microRNA represses human c-Myc expression and function.

Authors:  Apana A L Takwi; Yan Li; Lindsey E Becker Buscaglia; Jingwen Zhang; Saibyasachi Choudhury; Ae Kyung Park; Mofang Liu; Ken H Young; Woong-Yang Park; Robert C G Martin; Yong Li
Journal:  EMBO Mol Med       Date:  2012-08-07       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.